Tirzepatide Gallery
$$MultiPurposeText$$
See examples of our Tirzepatide work and results.
What Our Clients Say
$$MultiPurposeText$$
Read testimonials from our satisfied customers
I've been to several IV therapy clinics over the past 10 years, and this is by far the bes...more
Great experience and feel 100% better!
So happy i found this place! Wonderful one on one care, great prices, excellent quality in...more
I had an amazing experience with Nurse Sharmaine. She was so friendly and knowledge. The t...more
Sharnine was wonderful! She was friendly, knowledgeable, and honest. I had questions about...more
The place is very clean and calm, Sharmaine was very professional, knowledgeable, answere...more
Frequently Asked Questions
Get answers to common questions about Tirzepatide.
Tirzepatide acts on GLP-1 and GIP receptors to reduce appetite, slow gastric emptying, and improve insulin sensitivity. Dosing is carefully titrated and combined with lifestyle guidance while clinicians monitor progress and address adverse effects.
Ideal candidates are adults with overweight or obesity seeking medically supervised weight loss or those needing improved glycemic control. We screen medical history, assess contraindications, and create individualized plans with monitoring and support.
Common side effects include nausea, vomiting, diarrhea, constipation, and transient appetite changes, typically dose-related and improving with time. Serious reactions are rare; we monitor closely and adjust therapy if needed.
Tirzepatide is given as a once-weekly subcutaneous injection. Doses are started low and gradually increased, with clinic training offered for self-administration and regular follow-ups to adjust therapy and review labs.
Many patients notice reduced appetite within weeks and measurable weight loss within several weeks to months. Magnitude and timeline vary by individual, dose, adherence, and lifestyle changes; clinicians track progress and adjust plans.
Tirzepatide can affect blood sugar and may interact with insulin or sulfonylureas, increasing hypoglycemia risk. Inform us of all medications; we review interactions and coordinate dose adjustments with your prescribing providers as needed.